BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1464476)

  • 1. Activation of spleen cell lytic activity by the alkaloid thiophosphoric acid derivative: Ukrain.
    Liepins A; Nowicky JW
    Int J Immunopharmacol; 1992 Nov; 14(8):1437-42. PubMed ID: 1464476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
    Liepins A; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of Chelidonium majus L. alkaloid thiophosphoric acid conjugates (Ukrain) on the phenotype of normal human lymphocytes.
    Slesak B; Nowicky JW; Harłozinska A
    Drugs Exp Clin Res; 1992; 18 Suppl():17-21. PubMed ID: 1305038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ukrain, an alkaloid thiophosphoric acid derivative of Chelidonium majus L. protects human fibroblasts but not human tumour cells in vitro against ionizing radiation.
    Cordes N; Plasswilm L; Bamberg M; Rodemann HP
    Int J Radiat Biol; 2002 Jan; 78(1):17-27. PubMed ID: 11747550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of macrophage tumouricidal activity by the alkaloid derivative Ukrain. In vitro and in vivo studies.
    Sotomayor EM; Rao K; Lopez DM; Liepins A
    Drugs Exp Clin Res; 1992; 18 Suppl():5-11. PubMed ID: 1305044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proapoptotic activity of Ukrain is based on Chelidonium majus L. alkaloids and mediated via a mitochondrial death pathway.
    Habermehl D; Kammerer B; Handrick R; Eldh T; Gruber C; Cordes N; Daniel PT; Plasswilm L; Bamberg M; Belka C; Jendrossek V
    BMC Cancer; 2006 Jan; 6():14. PubMed ID: 16417634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic central pharmacological properties of thiophosphoric acid alkaloid derivatives from Chelidonium majus L.
    Kleinrok Z; Jagiełło-Wójtowicz E; Matuszek B; Chodkowska A
    Pol J Pharmacol Pharm; 1992; 44(3):227-39. PubMed ID: 1470561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro toxicity of Ukrain against human Ewing tumor cell lines.
    Lanvers-Kaminsky C; Nolting DM; Köster J; Schröder A; Sandkötter J; Boos J
    Anticancer Drugs; 2006 Oct; 17(9):1025-30. PubMed ID: 17001175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. ("Ukrain") as an immunostimulant in patients with various carcinomas.
    Nowicky JW; Staniszewski A; Zbroja-Sontag W; Slesak B; Nowicky W; Hiesmayr W
    Drugs Exp Clin Res; 1991; 17(2):139-43. PubMed ID: 1713821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ukrain both as an anti cancer and immunoregulatory agent.
    Nowicky JW; Manolakis G; Meijer D; Vatanasapt V; Brzosko WJ
    Drugs Exp Clin Res; 1992; 18 Suppl():51-4. PubMed ID: 1305045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ukrain(TM), a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines.
    Panzer A; Hamel E; Joubert AM; Bianchi PC; Seegers JC
    Cancer Lett; 2000 Nov; 160(2):149-57. PubMed ID: 11053644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation.
    Boyko VN; Zholus RB
    Drugs Exp Clin Res; 1998; 24(5-6):331-3. PubMed ID: 10190098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological appreciation of the stomach after the application of thiophosphoric acid derivatives of Chelidonium majus L. (Ukrain) alkaloids.
    Matysek M; Królikowska-Prasał I; Jedrych B
    Ann Univ Mariae Curie Sklodowska Med; 1992; 47():123-6. PubMed ID: 1365782
    [No Abstract]   [Full Text] [Related]  

  • 14. Estimation of direct influence of Ukrain preparation on influenza viruses and the bacteria E. coli and S. aureus.
    Ciebiada I; Korczak E; Nowicky JW; Denys A
    Drugs Exp Clin Res; 1996; 22(3-5):219-23. PubMed ID: 8899335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ukrain (NSC-631570) in experimental and clinical studies: a review.
    Jagiello-Wójtowicz E; Kleinrok Z; Urbanska EM
    Drugs Exp Clin Res; 1998; 24(5-6):213-9. PubMed ID: 10190077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of thiophosphoric acid alkaloid derivatives from Chelidonium majus L. (Ukrain) on ovalbumin antigenicity and antiovalbumin IgE antibody response in mice.
    Wyczółkowska J; Michoń T; Nowicky JW
    Drugs Exp Clin Res; 1996; 22(3-5):195-200. PubMed ID: 8899330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ukrain (NSC-631570) influences on bone status: a review.
    Jabłoński M
    Drugs Exp Clin Res; 2000; 26(5-6):317-20. PubMed ID: 11345045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of Ukrain, a cytostatic and immunomodulating drug, on effects of irradiation.
    Boyko VN; Voltchek IV; Petrov AS; Bubnov VP
    Drugs Exp Clin Res; 1996; 22(3-5):167-71. PubMed ID: 8899323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical analyses of Ukrain, a semi-synthetic Chelidonium majus alkaloid derivative, fail to confirm its trimeric structure.
    Panzer A; Joubert AM; Eloff JN; Albrecht CF; Erasmus E; Seegers JC
    Cancer Lett; 2000 Nov; 160(2):237-41. PubMed ID: 11053654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Ukrain on the growth and metastasizing of Lewis carcinoma in C57BL/6 mice.
    Grinevich Y; Shalimov S; Bendyuh G; Zahriychuk O; Hodysh Y
    Drugs Exp Clin Res; 2005; 31(2):59-70. PubMed ID: 15929607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.